Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이진화 | * |
dc.date.accessioned | 2016-08-28T11:08:19Z | - |
dc.date.available | 2016-08-28T11:08:19Z | - |
dc.date.issued | 2010 | * |
dc.identifier.issn | 1738-3536 | * |
dc.identifier.other | OAK-13467 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/229459 | - |
dc.description.abstract | Background: The increasing rate of drug-resistant tuberculosis (TB) is a threat to the public health and TB control. In Korea, about 75-80% of TB patients are treated in private hospitals and the rate has been continuously increasing since 2000. Methods: On a retrospective basis, we enrolled 170 newly diagnosed with or retreated for multidrug-resistant TB (MDR-TB) in 2004 from 21 private hospitals. We extracted the following demographics and treatment history from patient medical records: initial treatment outcomes, cumulative survival rates, treatment outcomes, and prognostic factors. Results: Of the 170 patients, the majority were male (64.1%), the mean age was 44.5 years old, and mean body-mass-index was 20.2 kg/m2. None of the patients tested positive for HIV. Eleven (6.5%) were confirmed to have extensively drug-resistant TB (XDR-TB) at treatment initiation. Treatment success rates were not different between XDR-TB (36.4%, 4/11) and non-XDR MDR-TB (51.6%, 82/159). Default rate was high, 21.8% (37/170). Far advanced disease on X-ray was a significant negative predictor of treatment success; advanced disease and low BMI were risk factors for all-cause mortality. Conclusion: In private hospitals in Korea, the proportion of XDR-TB in MDR-TB was comparable to previous data. The treatment success rate of MDR-/XDR-TB remains poor and the failure rate was quite high. Adequate TB control policies should be strengthened to prevent the further development and spread of MDR-/XDR-TB in Korea. Copyright©2010. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. | * |
dc.language | Korean | * |
dc.title | Treatment outcomes and prognostic factors in patients with multidrug-resistant tuberculosis in Korean private hospitals | * |
dc.type | Article | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 69 | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.startpage | 95 | * |
dc.relation.lastpage | 102 | * |
dc.relation.journaltitle | Tuberculosis and Respiratory Diseases | * |
dc.identifier.doi | 10.4046/trd.2010.69.2.95 | * |
dc.identifier.scopusid | 2-s2.0-77956675840 | * |
dc.author.google | Park J.K. | * |
dc.author.google | Koh W.-J. | * |
dc.author.google | Kim D.K. | * |
dc.author.google | Kim E.K. | * |
dc.author.google | Kim Y.I. | * |
dc.author.google | Kim H.J. | * |
dc.author.google | Kim T.-H. | * |
dc.author.google | Kim J.Y. | * |
dc.author.google | Park M.S. | * |
dc.author.google | Park I.-N. | * |
dc.author.google | Park J.S. | * |
dc.author.google | Lee K.M. | * |
dc.author.google | Song S.H. | * |
dc.author.google | Lee J.H. | * |
dc.author.google | Lee S.H. | * |
dc.author.google | Lee H.P. | * |
dc.author.google | Yim J.-J. | * |
dc.author.google | Lim J. | * |
dc.author.google | Jegal Y.J. | * |
dc.author.google | Jung K.H. | * |
dc.author.google | Huh J.W. | * |
dc.author.google | Choi J.C. | * |
dc.author.google | Shim T.S. | * |
dc.contributor.scopusid | 이진화(56646645800;58376333800) | * |
dc.date.modifydate | 20240419140935 | * |